News & Press Releases Swedish

Kallelse till årsstämma i Scandinavian ChemoTech AB

Scandinavian ChemoTech AB, org.nr 556937-9547, håller årsstämma den 14 maj 2024 kl. 13.30 i Redeye AB:s lokaler, Mäster Samuelsgatan 42, i Stockholm. Anmälan m.m. Den som önskar delta i stämman ska: (i) vara upptagen som aktieägare i den av Euroclear Sweden AB framställda aktieboken avseende förhållanden på avstämningsdagen som är den 3 maj 2024 och (ii) anmäla…

Read more

ChemoTech gör framsteg genom att erhålla patentskydd för två viktiga patent i Indien

Scandinavian ChemoTech AB meddelar idag att bolaget har beviljats två betydande patentgodkännanden av The Patent Office, Government of India. Detta innebär att det inte kommer att finnas något krav på att delta i offentliga upphandlingar. I stället kommer en förenklad upphandlingsprocess att ske. Patentverket i Indien har godkänt ytterligare två av Bolagets patentansökningar. Det nu…

Read more

Scandinavian ChemoTechs Animal Care ger sig ut på en spännande resa tillsammans med Equitom genom att skapa ett banbrytande Centre of Excellence

Vetiqure utökar sitt partnerskap med Equitom, Europas främsta hästklinik känd för sina banbrytande framsteg inom hästsjukvård, genom att etablera ett Centre of Excellence för TSE. Med sitt framstående rykte och status som den största och mest innovativa hästkliniken i Europa har Equitom konsekvent tänjt på gränserna för hästsjukvård. Vetiqures TSE-teknologi anses av Equitom som banbrytande…

Read more

News & Press Releases English

ChemoTech attains progress by obtaining patent protection for two essential patents in India

Scandinavian ChemoTech AB today announces that it has been granted two significant patent approvals by The Patent Office, Government of India. This implies that there won't be a requirement to engage in public tenders; rather, a simplified procurement process will be in place. The Patent Office, Government of India has approved two of the Company's…

Read more

Scandinavian ChemoTech’s Animal Care embarks on an exciting journey along with Equitom to forge a cutting-edge Centre of Excellence

Vetiqure are expanding their partnership with Equitom, Europe's foremost equine clinic renowned for its groundbreaking advancements in equine healthcare, by establishing a Centre of Excellence for TSE. With its distinguished reputation and status as the largest and most innovative equine clinic in Europe, Equitom has consistently pushed the boundaries of equine medicine. Vetiqure's TSE technology…

Read more

ChemoTech secures order from the largest European state-of-the-art equine (horse) clinic

Scandinavian ChemoTech's Animal Care is delighted to confirm the receipt of an order of €48k from Europe's foremost equine clinic, EquiTom, Lummen in Belgium, distinguished for its pioneering advancements in equine healthcare. With a stellar reputation and being the largest, most innovative equine clinic in Europe with a hospitalisation capacity of more than 150 horses,…

Read more

ChemoTech Videos

2023

Invest Live | Emissionsaktuella AcuCort & ChemoTech presenterar med Q&A (Swedish)

Redeye Investor Forum - Company Presentation

Clinical strategy update from Medical Director Dr. Suhail Mufti

Redeye Fight Cancer Day 2023 - ChemoTech

2022

ChemoTech 2022 - Mohan Frick CEO summarises the year (Swedish)

ChemoTech Q2 2022 - Livestream Presentation (in Swedish)

SWECARE at EXPO 2020 DUBAI: "Closing Ceremony"

A conversation with Småbolagspodden

(Audio in Swedish)

I det senaste avsnittet av Småbolagspodden berättar Scandinavian ChemoTechs vd Mohan Frick om hur bolagets unika metod för cancerbehandling, via så kallad tumörspecifik elektroporation, ska hjälpa människor och djur världen över.

Lyssna på hela avsnittet här:
52. ChemoTech – Vill vara en kraft för skonsammare cancervård

2021

Presentation of Q3 - Analysera med oss November 2021 (Swedish)

ChemoTech presents for its upcoming Annual General meeting 24 May 2021. Spoken language is Swedish but the presentation is in English.

Innovative TSE technology increases the local effect of chemotherapy (Swedish)

ChemoTech answers questions from the shareholders; Part 1 (Swedish)

CEO Mohan Frick presenting at Erik Penser Bank Bolagsdag (Swedish)

Erik Penser Bank interview with CEO Mohan Frick (Swedish) 8 January 2021

Videos from 2020

Company Presentation of the Q3 report (Swedish) 11th of November 2020

Company Presentation (Swedish) 27th of October 2020

Videos from 2019

Share Day in Gothenburg, November 4 2019 (Swedish)

Videos from 2018

Share analysis ChemoTech Q2 2018 (Swedish)

Share Day in Malmö on May 22, 2018 (Swedish)

Our foundation

Our profound knowledge in electroporation forms the starting point for the company’s existing product and R&D projects: The IQwave™ specially designed for our TSE™ – Tumour Specific Electroporation technology which treats a range of various tumours.

Our research focus

Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.